Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
ACTRIMS-ECTRIMS 2014 -- Day 3, morning
CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier.
Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.
Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients.
CMSC ACTRIMS Cooperative Annual Meeting
CSF Metabolite Analysis May Offer Sensitive Biomarkers for MS
Mycophenolate Mofetil as a Monotherapy in Multiple Sclerosis: a multicentre retrospective study on 361 patients
MS Research Roundup: November 21, 2014
Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity.
Untangling TNF Trouble
MS Research Roundup: January 17, 2014
Low testosterone is associated with disability in men with multiple sclerosis.
Combination of IFN beta-1a (Avonex) and mycophenolate mofetil (Cellcept) in multiple sclerosis.
High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS): A 3-Year Interim Report.
Mycophenolate mofetil improves neurological function and alters blood T-lymphocyte subsets in rats with experimental autoimmune encephalomyelitis.
The origin and application of experimental autoimmune encephalomyelitis.
Episode 50 with Dr. David Tabby on balance vests for MS
ISN-APSN Biennial Meeting
TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.
MS Patient, Ph.D.: Can We Separate Anxiety and Gender in MS?
RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation.
ACTRIMS-ECTRIMS 2014 -- Day 4
Episode 65 with Dr. Gisela Kobelt on the economics of long-term brain health in MS
USPTO list of patent term extensions
Episode 40 with Dr. Raj Kapoor on a clinical trial of phenytoin
Pages
« first
‹ previous
…
42
43
44
45
46
47
48
49
50
…
next ›
last »
